16.12.2012 Views

24/06/2005 - Controller General of Patents, Designs, and Trade Marks

24/06/2005 - Controller General of Patents, Designs, and Trade Marks

24/06/2005 - Controller General of Patents, Designs, and Trade Marks

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(12) PATENT APPLICATION PUBLICATION<br />

(19) INDIA (21)<br />

(22) Date <strong>of</strong> filing <strong>of</strong> Application: 27/<strong>06</strong>/2003 (43)<br />

(54) Title <strong>of</strong> the invention:<br />

Application No: 657/MUMNP/2003 A<br />

Publication Date: <strong>24</strong>/<strong>06</strong>/<strong>2005</strong><br />

IN VITRO METHOD FOR TRANSFECTION OF EUKARYOTIC CELL FOR<br />

PRODUCING DRUG FOR NON-VIRAL GENE THERAPY<br />

(51) International Classification : C 12 N 15/87 (71)<br />

(31) Priority Document No. : 101 00 996.8<br />

(32) Priority Date : 10/01/2001<br />

(33) Name <strong>of</strong> priority country : GERMANY<br />

(86)<br />

International Application<br />

No.<br />

: PCT/DE02/00<strong>06</strong>0<br />

Filing Date : 10/01/2002<br />

(87) International Publication<br />

No.<br />

: WO 02/055721 A2<br />

(61) Patent <strong>of</strong> addition to<br />

Application No.<br />

: NIL<br />

Filed on : N.A.<br />

(62) Divisional to Application<br />

No.<br />

: NIL<br />

Filed on : N.A.<br />

(57) Abstract:<br />

The invention relates to a method for the transfection <strong>of</strong> cells using<br />

at least one protein capable <strong>of</strong> forming nucleoprotein filaments. Said<br />

protein is first modified by at least one functional constituent which<br />

influences at least one step <strong>of</strong> the transfection, <strong>and</strong> the nucleic acid<br />

to be transfected is then loaded with the modified protein. The<br />

nucleic acid <strong>and</strong> the protein form a filamentary complex, <strong>and</strong> said<br />

complex is then added to the cells to be transfected. The invention<br />

also relates to a transfection agent <strong>of</strong> nucleoprotein filaments (NPF),<br />

at least one protein forming a nucleoprotein filament being modified<br />

by at least one functional constituent for the transfection. The<br />

invention further relates to the use <strong>of</strong> the inventive transfection agent<br />

for producing a medicament for the gene therapeutic treatment <strong>of</strong><br />

humans <strong>and</strong> animals. Finally, the invention relates to corresponding<br />

pharmaceutical preparations, especially for use in gene therapy, <strong>and</strong><br />

the use <strong>of</strong> such transfection agents in the form <strong>of</strong> constituents in kits.<br />

(72)<br />

Name <strong>of</strong> the Applicant:<br />

AMAXA GMBH<br />

Address <strong>of</strong> the Applicant:<br />

NATTERMANNALLEE 1,<br />

50829 KOLN, GERMANY.<br />

Name <strong>of</strong> the Inventors:<br />

1. SCHMIDT HANNS-MARTIN<br />

2. ALTROGGE LUDGER<br />

3. LENZ DIETMAR<br />

4. RIEMEN GUDULA<br />

5. BROSTERHUS HELMUT<br />

6. LORBACH ELKE<br />

7. HELFRICH JULIANA<br />

8. HEIN KATHARINA<br />

9. GREMSE MARION<br />

10. MALES TATJANA<br />

11. CHRISTINE RAINER<br />

12. SIEBENKOTTEN GREGOR<br />

13. ORTMANN BODO<br />

14. TURBANSKI TAMARA<br />

15. KLAES ANDREA<br />

Filed U/S 5(2) before the<br />

<strong>Patents</strong> (Amendment)<br />

Ordinance, 2004: NO<br />

(FIG.: 20)<br />

Total Pages: 77.<br />

The Patent Office Journal <strong>24</strong>.<strong>06</strong>.<strong>2005</strong> 17808

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!